Haemonetics
The role owns downstream marketing execution for Haemonetics Interventional Technologies (IVT), translating product strategy and clinical evidence into commercial content, field‑ready tools, and go‑to‑market execution across global regions. The incumbent drives launch planning, creates promotional and educational programs, conducts market analysis, and partners with product management and international teams to ensure commercial readiness and regulatory compliance.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
1971
Haemonetics provides a suite of innovative medical technology solutions that improve the quality, effectiveness and efficiency of care. We challenge ourselves to think big and make new possibilities a reality, so that our customers can make it matter for patients, every single day..
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Haemonetics.
7% above the average for this role
Haemonetics Wins FDA Nod For Persona PLUS Plasma Growth Opportunity
6 days ago
EMEA Principal Product Manager Downstream Marketing, Interventional Cardiology
W&B Scientific, Inc.
Interventional Development Manager/ Senior Manager (IDM)
SI-BONE, Inc
Sr. Product Manager
Medtronic
Interventional Cardiology Marketing Manager
bostonscientific
Account Manager, Coronary
Abbott Laboratories
Senior Manager, Downstream Marketing (Remote)
Stryker